BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23067574)

  • 21. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
    Maroni P; Matteucci E; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
    Breast Cancer Res Treat; 2011 Sep; 129(2):433-50. PubMed ID: 21069452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity.
    García-Rocha R; Moreno-Lafont M; Mora-García ML; Weiss-Steider B; Montesinos JJ; Piña-Sánchez P; Monroy-García A
    Cytokine; 2015 Dec; 76(2):382-390. PubMed ID: 26343835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer.
    Wu J; Zhou XJ; Sun X; Xia TS; Li XX; Shi L; Zhu L; Zhou WB; Wei JF; Ding Q
    Br J Cancer; 2017 Aug; 117(5):675-684. PubMed ID: 28683467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.
    Chang CP; Chio CC; Cheong CU; Chao CM; Cheng BC; Lin MT
    Clin Sci (Lond); 2013 Feb; 124(3):165-76. PubMed ID: 22876972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
    Nilsson UW; Jönsson JA; Dabrosin C
    Exp Cell Res; 2009 Jan; 315(1):1-9. PubMed ID: 18996114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of PPAR-α induces cell cycle arrest and inhibits transforming growth factor-β1 induction of smooth muscle cell phenotype in 10T1/2 mesenchymal cells.
    Lien SC; Wei SY; Chang SF; Chang MD; Chang JY; Chiu JJ
    Cell Signal; 2013 May; 25(5):1252-63. PubMed ID: 23385087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.
    Costea DE; Hills A; Osman AH; Thurlow J; Kalna G; Huang X; Pena Murillo C; Parajuli H; Suliman S; Kulasekara KK; Johannessen AC; Partridge M
    Cancer Res; 2013 Jul; 73(13):3888-901. PubMed ID: 23598279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming Growth Factor-beta 1 Involved in the Pathogenesis of Endometriosis through Regulating Expression of Vascular Endothelial Growth Factor under Hypoxia.
    Yu YX; Xiu YL; Chen X; Li YL
    Chin Med J (Engl); 2017 Apr; 130(8):950-956. PubMed ID: 28397725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage.
    Narita Y; Yamawaki A; Kagami H; Ueda M; Ueda Y
    Cell Tissue Res; 2008 Sep; 333(3):449-59. PubMed ID: 18607632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
    J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells.
    Noda S; Yashiro M; Nshii T; Hirakawa K
    Eur J Cancer; 2010 Mar; 46(5):995-1005. PubMed ID: 20144860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-β1 regulates differentiation of bone marrow mesenchymal stem cells.
    Zhao L; Hantash BM
    Vitam Horm; 2011; 87():127-41. PubMed ID: 22127241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic preconditioning potentiates the trophic effects of mesenchymal stem cells on co-cultured human primary hepatocytes.
    Qin HH; Filippi C; Sun S; Lehec S; Dhawan A; Hughes RD
    Stem Cell Res Ther; 2015 Dec; 6():237. PubMed ID: 26626568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-beta1 is elevated in breast cancer tissue and regulates nitric oxide production from a number of cellular sources during hypoxia re-oxygenation injury.
    Toomey D; Condron C; Wu QD; Kay E; Harmey J; Broe P; Kelly C; Bouchier-Hayes D
    Br J Biomed Sci; 2001; 58(3):177-83. PubMed ID: 11575741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells.
    Zhou Y; Zuo D; Wang M; Zhang Y; Yu M; Yang J; Yao Z
    Genes Cells; 2014 Sep; 19(9):676-91. PubMed ID: 25130457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of transforming growth factor β signaling in chronic rhinosinusitis.
    Li YC; An YS; Wang T; Zang HR
    Chin Med J (Engl); 2013; 126(17):3340-3. PubMed ID: 24033961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.